Li Luo

机构：University Medical Center Groningen, Central South University, University of Groningen, Guilin Medical University, Shanghai CASB Biotechnology (China), Chengdu Military General Hospital, Zhejiang Hospital, The First People's Hospital of Changde, Chengdu Center for Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, New York University, Guangdong Ocean University, Chongqing Medical University · ORCID：0000-0001-7855-4669

发表论文 63 篇 · 总被引 368 次 · h-index 12

代表论文

• Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia (2024 · Journal of the American College of Cardiology · 被引 28)
• Association between systemic immune-inflammatory index and systemic inflammatory response index with body mass index in children and adolescents: a population-based study based on the National Health and Nutrition Examination Survey 2017-2020 (2024 · Frontiers in Endocrinology · 被引 16)
• Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis (2025 · British Journal of Cancer · 被引 11)
• Association of pentachlorophenol in urine and follicular fluid with ovarian reserve and reproductive outcomes among women undergoing in vitro fertilization based on a prospective cohort study (2025 · Environmental Research · 被引 7)
• Experimental study on the mechanical behavior of artificially prepared stratified soil in triaxial compression tests (2024 · Acta Geotechnica · 被引 5)
• An increase in albuminuria is associated with a higher incidence of malignancies (2024 · Clinical Kidney Journal · 被引 5)